| Announce Date | 10/29/2025 |
| EPS Normalized Actual | $9.83 (Beat by $0.57) |
| EPS GAAP Actual | $9.83 (Beat by $0.57) |
| Revenue Actual | $2.316B |
| Revenue Surprise | Beat by $2316M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $0 |
| EPS GAAP Estimate | $0 |
| Revenue Estimate | $2.547132382B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 22.55 | 37.61 | 21.88204 | 23.60753 | 3 |
| Dec 2028 | 18.68333 | 45.39 | 18.15463 | 19.25743 | 6 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 3.82 | 0.67567 | 2.316B | 4.97% | -57.7M |
| FQ2 2025 (Jun 2025) | 3.76 | 0.4928 | 2.256B | 4.3% | -139.19M |
| FQ1 2025 (Mar 2025) | 3.52 | 3.52 | 2.225B | 4.4% | 2225M |
| FQ4 2024 (Dec 2024) | -0.14 | -0.14 | 2.261B | 6.66% | 2261M |
| FQ3 2024 (Sep 2024) | 3.11 | 3.11 | 2.201B | 6.36% | 2201M |
| FQ2 2024 (Jun 2024) | 3.16 | 3.16 | 2.159B | 6.51% | 2159M |
| FQ1 2024 (Mar 2024) | 2.44 | 2.44 | 2.127B | 6.06% | 2127M |
| FQ4 2023 (Dec 2023) | 2.41 | 2.41 | 2.11049B | 11.35% | 2110.49M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
0
Consensus Revenue Estimates
2.547132382B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 4.79 | -- | 4.76048 | 4.81918 | 4 |
| FQ3 2027 (Sep 2027) | 4.67 | -- | 4.67 | 4.67 | 5 |
| FQ2 2027 (Jun 2027) | 4.37 | -- | 4.37 | 4.37 | 5 |
| FQ1 2027 (Mar 2027) | 4.16 | -- | 4.13436 | 4.18534 | 4 |
| FQ4 2026 (Oct 2026) | 0 | -- | 0 | 0 | 5 |
| FQ3 2026 (Jul 2026) | 0 | -INF | 0 | 0 | 5 |
| FQ2 2026 (Jun 2026) | 0 | -INF | 0 | 0 | 4 |
| FQ1 2026 (Mar 2026) | 0 | -INF | 0 | 0 | 4 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 2.83B | -- | 2.82B | 2.84B | 14 |
| FQ3 2027 (Sep 2027) | 2.78B | -- | 2.78B | 2.78B | 9 |
| FQ2 2027 (Jun 2027) | 2.69B | -- | 2.69B | 2.69B | 9 |
| FQ1 2027 (Mar 2027) | 2.59B | -- | 2.57B | 2.6B | 10 |
| FQ4 2026 (Oct 2026) | 2.63B | -- | 2.61B | 2.69B | 6 |
| FQ3 2026 (Jul 2026) | 2.57B | 10.05 | 2.55B | 2.63B | 6 |
| FQ2 2026 (Jun 2026) | 2.59B | 13.05 | 2.56B | 2.62B | 10 |
| FQ1 2026 (Mar 2026) | 2.55B | 12.65 | 2.52B | 2.58B | 10 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
6
Revenue # of Misses
2
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 3.14433 | 3.82 | 0.67567 | 17.69% |
| FQ2 2025 (Jun 2025) | 3.2672 | 3.76 | 0.4928 | 13.11% |
| FQ1 2025 (Mar 2025) | 3.52 | 3.52 | 100% | |
| FQ4 2024 (Dec 2024) | -0.14 | -0.14 | 100% | |
| FQ3 2024 (Sep 2024) | 3.11 | 3.11 | 100% | |
| FQ2 2024 (Jun 2024) | 3.16 | 3.16 | 100% | |
| FQ1 2024 (Mar 2024) | 2.44 | 2.44 | 100% | |
| FQ4 2023 (Dec 2023) | 2.41 | 2.41 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $2.37B | $2.32B | $-57.7M | -2.49% |
| FQ2 2025 (Jun 2025) | $2.4B | $2.26B | $-139.19M | -6.17% |
| FQ1 2025 (Mar 2025) | $0B | $2.23B | $2225M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $2.26B | $2261M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $2.2B | $2201M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $2.16B | $2159M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $2.13B | $2127M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $2.11B | $2110.49M | 100% |